| Date Filed | Type | Description |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/09/2023 |
4
| Szyman Catherine M. (CVP, Critical Care) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Sold 5,000 shares
@ $78.637, valued at
$393.2k
Exercised 5,000 options to buy
@ $36.75, valued at
$183.8k
|
|
| 08/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/10/2023 |
4
| Szyman Catherine M. (CVP, Critical Care) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Paid exercise price by delivering 252 shares
@ $90.46, valued at
$22.8k
Sold 5,000 shares
@ $90.52, valued at
$452.6k
Exercised 5,000 options to buy
@ $36.75, valued at
$183.8k
|
|
| 05/31/2023 |
4
| Szyman Catherine M. (Director) has filed a Form 4 on Outset Medical, Inc.|
Txns:
| Granted 7,681 shares
@ $0 |
|
| 05/19/2023 |
4
| Szyman Catherine M. (Director) has filed a Form 4 on Inari Medical, Inc.|
Txns:
| Granted 2,412 shares
@ $0 |
|
| 05/15/2023 |
4
| Szyman Catherine M. (CVP, Critical Care) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Granted 6,525 shares
@ $0
Granted 50,400 options to buy
@ $88.78, valued at
$4.5M
Granted 8,175 options to buy
@ $0 |
|
| 05/09/2023 |
4
| Szyman Catherine M. (CVP, Critical Care) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Paid exercise price by delivering 2,154 shares
@ $88.74, valued at
$191.1k
Paid exercise price by delivering 1,376 shares
@ $88.74, valued at
$122.1k
Sold 75,600 shares
@ $88.9449, valued at
$6.7M
Exercised 4,708 options to buy
@ $0
Exercised 75,600 options to buy
@ $35.1967, valued at
$2.7M
|
|
| 05/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/04/2023 |
4
| Szyman Catherine M. (CVP, Critical Care) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Paid exercise price by delivering 327 shares
@ $87.81, valued at
$28.7k
Paid exercise price by delivering 344 shares
@ $88.1, valued at
$30.3k
|
|
| 02/13/2023 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2022 |
4
| Szyman Catherine M. (Director) has filed a Form 4 on Outset Medical, Inc.|
Txns:
| Granted 6,880 shares
@ $0 |
|
| 05/27/2022 |
4
| Szyman Catherine M. (Director) has filed a Form 4 on Inari Medical, Inc.|
Txns:
| Granted 2,420 shares
@ $0 |
|
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/11/2022 |
4
| Szyman Catherine M. (CVP, Critical Care) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Sold 3,600 shares
@ $122.1192, valued at
$439.6k
Sold 6,579 shares
@ $123.0007, valued at
$809.2k
Sold 9,821 shares
@ $121.3688, valued at
$1.2M
Exercised 20,000 options to buy
@ $21.76, valued at
$435.2k
|
|
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2022 |
4
| Szyman Catherine M. (CVP, Critical Care) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Sold 6,900 shares
@ $105.7361, valued at
$729.6k
Sold 13,100 shares
@ $106.6163, valued at
$1.4M
Exercised 20,000 options to buy
@ $21.76, valued at
$435.2k
|
|
| 01/14/2022 |
4
| Szyman Catherine M. (CVP, Critical Care) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Sold 1,116 shares
@ $120.0129, valued at
$133.9k
Sold 8,884 shares
@ $119.4652, valued at
$1.1M
Exercised 10,000 options to buy
@ $21.76, valued at
$217.6k
|
|
| 12/17/2021 |
4
| Szyman Catherine M. (CVP, Critical Care) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Sold 10,000 shares
@ $121.24, valued at
$1.2M
Exercised 10,000 options to buy
@ $21.76, valued at
$217.6k
|
|
| 11/19/2021 |
4
| Szyman Catherine M. (CVP, Critical Care) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Sold 1,253 shares
@ $118.8724, valued at
$148.9k
Sold 2,390 shares
@ $116.9817, valued at
$279.6k
Sold 6,357 shares
@ $117.8849, valued at
$749.4k
Exercised 10,000 options to buy
@ $21.76, valued at
$217.6k
|
|
| 10/18/2021 |
4
| Szyman Catherine M. (CVP, Critical Care) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Sold 2,603 shares
@ $110.8715, valued at
$288.6k
Sold 7,138 shares
@ $110.2386, valued at
$786.9k
Exercised 9,741 options to buy
@ $21.76, valued at
$212k
|
|
| 09/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2021 |
4
| Szyman Catherine M. (CVP, Critical Care) has filed a Form 4 on Edwards Lifesciences Corp|
Txns:
| Sold 15,000 shares
@ $113.5269, valued at
$1.7M
Exercised 15,000 options to buy
@ $21.76, valued at
$326.4k
|
|
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Szyman Catherine M. (Director) has filed a Form 4 on Outset Medical, Inc.|
Txns:
| Granted 3,288 shares
@ $0 |
|
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|